EnliTISA (Shanghai) Pharmaceutical Co., Ltd.
3 clinical trials · Sponsor
◉ Watch EnliTISA (Shanghai) Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Adult Subjects After Subcutaneous Injection of TISA-818-Inj (NCT07337044) | EnliTISA (Shanghai) Pharmaceutical Co., Ltd. | 2024-01-24 |
| Safety and Preliminary Efficacy of TISA-818 Injection in Patients With Acute Respiratory Distress Syndrome (NCT07319351) | EnliTISA (Shanghai) Pharmaceutical Co., Ltd. | 2023-10-12 |
| UP-818-CC Injection in Healthy Chinese Subjects (NCT07355621) | EnliTISA (Shanghai) Pharmaceutical Co., Ltd. | 2022-02-14 |
Track EnliTISA (Shanghai) Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.